GSK announced several transactions involving the vesting and sale of ordinary shares under its Performance Share Plan and Deferred Investment Award Programme. The transactions involve key executives, ...

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...

Annual core operating profit increased in 2024 for British pharmaceutical company GSK compared to 2023, the company reported ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

U.S. Q3 GDP growth revised up to 2.9% on stronger consumer spending By Investing.com - Nov 30, 2022 1 By Geoffrey Smith Investing.com -- The U.S. economy grew faster than first thought in the ...

Pharmaceutical giant GSK and the University of Oxford have teamed up to make a vaccine that targets cells at the pre-cancerous stage. The university has world-leading expertise in the study of pre ...

GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).

In an interview with Gulf Business, Charles Leslie, global business lead for the Pain Portfolio & Systemics at Haleon, outlines key consumer health trends reshaping the healthcare sector ...

ETtech HUL-Minimalist acquisition: Mohit and Rahul Yadav, cofounders, Minimalist Hindustan Unilever Limited (HUL) said it will acquire a 90.5% stake in direct-to-consumer beauty brand Minimalist for ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight ... a wave of smaller deals from GSK, Eli Lilly and lesser known ...